News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.

Daiichi Sankyo Presents Updated Data for DS-8201 in Patients with HER2-Expressing Gastric Cancer at ASCO 2018 Gastrointestinal Cancers Symposium

Encouraging phase 1 results were shared at ASCO for DS-8201 (an antibody drug conjugate) treatment for HER2-positive gastric cancer.

Read Source
X